Visiting Professors

ResearchToPractice.com/VPC109 - Case 13: A 49-year-old man with inflammatory bowel disease presented with T3N1 rectal cancer and underwent complete mesorectal excision followed by adjuvant FOLFOX until CT revealed a hepatic lesion, at which point bevacizumab was added to the FOLFOX and the patient underwent resection of the hepatic lesion. Interviews conducted by Neil Love, MD. Produced by Research To Practice.